Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Pulse Azithromycin vs 6-week Doxycycline for Moderate to Severe Meibomian Gland Dysfunction
TCTR20180810001Phase 4Completed
- Sponsor
- Chiang Mai University
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin, doxycycline in meibomian gland dysfunction (MGD), sponsored by Chiang Mai University. Started Sep 2018; status: completed.
02
Drugs
azithromycindoxycycline
03
Conditions
meibomian gland dysfunction (MGD)
Beyond the preview
Go deeper on TCTR20180810001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180810001.